In comparison, caspase-1 deficiency upregulated 3 (6.5%) and downregulated 6 (13%) lipid peroxidation enzymes upregulated in NASH/NAFLD (Table 4(d)). This evidence concerns the gene CASP1 and metabolic dysfunction-associated steatotic liver disease.